Press releases

Medtronic Diabetes today announced the expansion of U.S. pharmacy formulary access for its MiniMed™ 780G insulin pump, through agreements with major pharmacy benefit managers (PBMs) and PBM...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its Diabetes business, which as previously announced will operate under the name MiniMed, has filed a...

Medtronic plc, a global leader in healthcare technology, today announced that Ryan Weispfenning, vice president and head of investor relations, has elected to join its Diabetes business to...

Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the broad U.S. commercial launch of the MiniMed™ 780G system integrated with the Instinct sensor, made by Abbott...

GALWAY, Ireland – September 16 – Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today presented compelling real-world evidence demonstrating that the MiniMed™ 780G...

Medtronic plc, a global leader in medical technology, announced it will present new data on its MiniMed™ 780G system at the upcoming European Association for the Study of Diabetes (EASD) 61st...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones that broaden the MiniMed™ 780G system...

Medtronic plc (NYSE: MDT), a global leader in medical technology, today announced CE (Conformité Européenne) Mark in Europe to expand indications of the MiniMed™ 780G system for use by...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the appointment of Chad Spooner as chief financial officer (CFO) of MiniMed, in advance of its intended...

Medtronic plc, a global leader in healthcare technology, is partnering with professional tennis player Alexander Zverev and his foundation to elevate global awareness of type 1 diabetes. Through...